MRI equipment use "must cease" in the EU - unless derogation possible under forthcoming law
This article was originally published in Clinica
Executive Summary
"I do not see how the Commission can address the threat to the future of MRI without proposing an EU-wide derogation for MRI from the scope of the [Physical Agents] Directive on public health grounds." That is the view of Professor Gabriel Krestin, professor and chairman of the Department of Radiology at Erasmus University in response to the publication of a new study by Professor Stuart Crozier, professor and director of the biomedical engineering group at the University of Queensland. Prof Crozier's report, published on June 14, demonstrates that changes to existing MRI practice would not be sufficient to comply with Directive 2004/40/EC, the EU Physical Agents Directive, which is due to be fully enforced in April 2008; thus, the use of current MRI equipment and procedures would need to stop.
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.